About That Finding…

Medical studies that show large effects often don't hold up under further scrutiny, a new paper published in the Journal of the American Medical Association says. Stanford University's John Ioannidis and his colleagues analyzed clinical trial data from the Cochrane Database of Systematic Reviews and found that "when additional evidence is obtained, most of the very large treatment effects become much smaller and many lose their nominal significance," the authors write.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.